High-Precision Cancer Control with Stereotactic Radiotherapy
Stereotactic radiotherapy (SRT) is a cutting-edge form of radiation treatment that delivers very high doses of radiation to tumours with extreme accuracy. Using advanced imaging and computer-guided technology, it targets cancer while sparing surrounding healthy tissues. Dr Carla Perna offers SRT to treat oligometastatic cancer (where cancer has spread to a limited number of sites), as well as selected cases of prostate and renal cancer. Her expertise ensures that patients receive precise, effective therapy with minimal disruption to their daily lives.
Send Enquiry
How Stereotactic Radiotherapy Works in Targeted Cancer Care
Stereotactic radiotherapy uses detailed scans and sophisticated planning software to map the tumour's exact shape and position. Treatment beams are then delivered from many angles, concentrating powerful radiation on the cancer while avoiding nearby organs. This approach is particularly useful for oligometastatic disease, helping control small secondary tumours, and can be used for certain prostate and renal cancers that need focused high-dose treatment. Dr Carla Perna carefully assesses tumour location, size, and previous treatments before recommending SRT. She also provides close follow-up to monitor progress and manage any side effects, ensuring patients benefit from advanced technology delivered with expert, compassionate care.
EXPLORE TREATMENTS
Accessible Cancer Treatments Tailored to Your Needs
My consultation with Dr Perna was very proficient and professional. She explained my condition well and has arranged for further tests to be carried out to determine the best and appropriate way forward. Would certainly recomend Dr Perna to other individuals.
My consultation with Dr Perna was very proficient and professional. She explained my condition well and has arranged for further tests to be carried out to determine the best and appropriate way forward. Would certainly recomend Dr Perna to other individuals.
My consultation with Dr Perna was very proficient and professional. She explained my condition well and has arranged for further tests to be carried out to determine the best and appropriate way forward. Would certainly recomend Dr Perna to other individuals.
Your stereotactic radiotherapy questions, answered.
Can't find what you're looking for?
How effective is stereotactic radiotherapy?
Stereotactic radiotherapy (SRT) is highly effective for precisely targeting and destroying small tumours while sparing nearby healthy tissue. It can control cancer growth, relieve symptoms, and sometimes delay the need for other treatments. Dr Carla Perna uses SRT specifically for oligometastatic disease, prostate cancer, and certain renal cancers, applying advanced planning and technology to achieve strong tumour control with minimal side effects.
How quickly will I recover after stereotactic radiotherapy?
Most people recover quickly after SRT because it’s non-invasive and highly targeted. Many return to normal activities within a day or two, though some may feel mild fatigue or soreness for a short time. Dr Carla Perna supports her oligometastatic, prostate, and renal cancer patients through recovery, monitoring side effects and helping them resume daily routines as comfortably as possible.
Which cancers can be treated with stereotactic radiotherapy?
SRT can be used for various cancers, especially when tumours are small and clearly defined. It’s often applied to brain, lung, liver, and bone lesions in general cancer care. However, Dr Carla Perna specifically uses stereotactic radiotherapy for oligometastatic disease, prostate cancer, and certain renal cancers, where precise, high-dose treatment offers effective control while limiting impact on surrounding tissues.
How many sessions are needed for stereotactic radiotherapy?
SRT is usually delivered in a small number of high-dose treatments, often between one and five sessions, rather than the many weeks typical of standard radiotherapy. For patients with oligometastatic, prostate, or renal cancers, Dr Carla Perna designs a personalised schedule, explaining the number and timing of sessions to match the tumour’s size, location, and response.
What types of cancer respond best to stereotactic radiotherapy?
Cancers with small, well-defined tumours respond best to SRT because the therapy can focus radiation very precisely. This includes limited metastatic spots (oligometastatic disease) and certain organ-based tumours such as those in the prostate or kidney. Dr Carla Perna uses SRT for these specific cancers, where it can effectively control disease and delay the need for broader, whole-body treatments.